Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PETScan: score-based genome-wide association analysis of RNA-Seq and ATAC-Seq data.

Bioinformatics (Oxford, England)·2026
Same author

Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease.

Aging cell·2025
Same author

Envelope-dimer epitope 1 (EDE1) antibody (C10) treatment significantly reduces Zika virus replication in the male and female reproductive tracts.

Journal of virology·2025
Same author

Delivery of a Muscle-Targeted Adeno-Associated Vector Via <i>Ex Vivo</i> Normothermic Perfusion Is Efficient, Durable, and Safe in a Preclinical Porcine Heart Transplant Model.

Transplant international : official journal of the European Society for Organ Transplantation·2025
Same author

Unbiased genetics identifies a glutamatergic signaling network as a mediator of daily sleep patterns.

bioRxiv : the preprint server for biology·2025
Same author

The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells.

mSphere·2025

Related Experiment Video

Updated: Jul 11, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs &amp; Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Gene delivery by lentivirus vectors.

Adam S Cockrell1, Tal Kafri

  • 1Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Molecular Biotechnology
|September 18, 2007
PubMed
Summary

Lentiviral vectors are advanced gene delivery tools for research and therapy, offering safe and stable gene expression. Their development has led to successful preclinical and clinical applications for genetic diseases.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Lentiviral vectors are key gene delivery vehicles due to their ability to transduce nondividing cells and provide long-term transgene expression.
  • Advances in lentiviral vector development focus on enhancing safety, including preventing replication-competent lentiviruses (RCLs), vector mobilization, and insertional mutagenesis.

Purpose of the Study:

  • To review recent advances in lentiviral vector development, production, and applications.
  • To highlight improvements in lentiviral vector safety and regulatory systems.
  • To summarize current and emerging applications in research and clinical settings.

Main Methods:

  • Discussion of lentiviral vector design and molecular regulatory systems for gene expression control.

More Related Videos

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue&#45;Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Related Experiment Videos

Last Updated: Jul 11, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs &amp; Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue&#45;Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

  • Presentation of state-of-the-art lentiviral vector production techniques, including transient transfection and packaging cell lines.
  • Description of methods for vector concentration, purification, titering, and safety assessment.

    • Main Results:

    • Sophisticated lentiviral vectors demonstrate improved safety profiles regarding RCLs, mobilization, and insertional mutagenesis.
    • Conventional molecular regulatory systems enable spatial and temporal control of gene expression.
    • Established protocols exist for lentiviral vector production, purification, and safety testing.

    Conclusions:

    • Lentiviral vectors are effective for generating transgenic animals and delivering RNA interference molecules.
    • Successful preclinical studies have paved the way for lentiviral vector transition into human clinical trials for various diseases.
    • Lentiviral vectors represent a promising therapeutic strategy for infectious and genetic diseases.